Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients

NCT02188368 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

45

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of enrollment

Conditions

Multiple Myeloma

Interventions

DRUG: POM
DRUG: Steroids
DRUG: PLD
DRUG: CFZ
DRUG: BTZ
DRUG: CLA
DRUG: CY

Sponsor

Oncotherapeutics

Collaborators

[object Object]